Cash flow ezCaretech Co., LTD

Stocks

A099750

KR7099750002

Software

End-of-day quote Korea S.E. Other stock markets 11/06/2026			5-day change	1st Jan Change
7,470.00 ^KRW	+5.66%		+7.48%	-17.55%

14/08/25	Ezcaretech wins 10.8 billion won order	RE
17/01/23	EzCaretech Co., LTD announced that it expects to receive KRW 9.89999856 billion in funding from Kakao Healthcare Co., Ltd.	CI

1d2b71341cc3368a.jxi5WG7LgH3X3TwDi1hQs3mby8ec7yWHEqJObNaeCo4.4EfvIR2t6BeUrW1AvTIa5BbMkobqgFPQdO9-M7DTb8zaQvYRIonYIrvpdQ

Published financial data: EZCARETECH CO., LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	76.9B	92.07B	73.19B	67.94B	72.64B
Other Revenues, Total	-	-	-	-	-
Total Revenues	76.9B	92.07B	73.19B	67.94B	72.64B
Cost of Goods Sold, Total	66.65B	74.89B	62.92B	56.01B	56.84B
Gross Profit	10.25B	17.19B	10.27B	11.94B	15.8B
Selling General & Admin Expenses, Total	10.57B	11.46B	8.96B	10.14B	10.68B
Provision for Bad Debts	-87.89M	1.8B	2.19B	-1.26B	-152M
R&D Expenses	516M	587M	878M	896M	1.12B
Depreciation & Amortization - (IS)	816M	1.11B	1.07B	1.22B	1.22B
Amortization of Goodwill and Intangible Assets - (IS)	1.74B	1.21B	730M	117M	122M
Other Operating Expenses	668M	428M	551M	586M	597M
Other Operating Expenses, Total	14.22B	16.59B	14.39B	11.7B	13.59B
Operating Income	-3.97B	591M	-4.12B	236M	2.21B
Interest Expense, Total	-111M	-204M	-323M	-230M	-95.9M
Interest And Investment Income	61.05M	58.86M	190M	380M	352M
Net Interest Expenses	-50.22M	-145M	-133M	150M	256M
Currency Exchange Gains (Loss)	-332M	530M	-543M	1.18B	567M
Other Non Operating Income (Expenses)	49.42M	431M	-68.07M	245M	-174M
EBT, Excl. Unusual Items	-4.3B	1.41B	-4.86B	1.81B	2.86B
Gain (Loss) On Sale Of Investments	1.45B	57.08M	80.62M	78M	268M
Gain (Loss) On Sale Of Assets	33.75M	965K	460K	1.25M	-26.48M
Asset Writedown	-4.96B	-3.88B	-4.29B	-	-199M
EBT, Incl. Unusual Items	-7.77B	-2.41B	-9.07B	1.89B	2.9B
Income Tax Expense	145M	779M	512M	682M	610M
Earnings From Continuing Operations	-7.92B	-3.19B	-9.59B	1.21B	2.29B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-7.92B	-3.19B	-9.59B	1.21B	2.29B
Minority Interest	-	-	-	-	-
Net Income - (IS)	-7.92B	-3.19B	-9.59B	1.21B	2.29B
Net Income to Common Incl Extra Items	-7.92B	-3.19B	-9.59B	1.21B	2.29B
Net Income to Common Excl. Extra Items	-7.92B	-3.19B	-9.59B	1.21B	2.29B
Per Share Items
Net EPS - Basic	-634.08	-254.95	-758.94	89.84	170.57
Basic EPS - Continuing Operations	-634.08	-254.95	-758.94	89.84	170.57
Basic Weighted Average Shares Outstanding	12.49M	12.51M	12.63M	13.44M	13.44M
Net EPS - Diluted	-634.08	-255	-759	89.84	170.5
Diluted EPS - Continuing Operations	-634.08	-255	-759	89.84	170.5
Diluted Weighted Average Shares Outstanding	12.49M	12.51M	12.63M	13.44M	13.44M
Normalized Basic EPS	-215.12	70.27	-240.7	84.18	132.99
Normalized Diluted EPS	-215.12	70.27	-240.7	84.18	132.99
Dividend Per Share	43	-	-	-	-
Payout Ratio	-6.78	-16.87	-	-	-
Supplemental Items
EBITDA	-1.23B	3.06B	-2.18B	1.67B	3.63B
EBITA	-2.23B	1.8B	-3.39B	353M	2.33B
EBIT	-3.97B	591M	-4.12B	236M	2.21B
EBITDAR	-874M	3.23B	-1.88B	1.88B	4B
Effective Tax Rate - (Ratio)	-1.87	-32.28	-5.64	36.1	21.01
Normalized Net Income	-2.69B	879M	-3.04B	1.13B	1.79B
Supplemental Operating Expense Items
Advertising Expense	127M	65.42M	29.91M	35.28M	50.9M
Selling and Marketing Expenses	933M	1.29B	1.47B	1.35B	1.11B
General and Administrative Expenses	187M	170M	190M	187M	303M
Research And Development Expense From Footnotes	516M	587M	878M	896M	1.12B
Net Rental Expense, Total	354M	169M	297M	202M	376M
Imputed Operating Lease Interest Expense	82.22M	42.71M	115M	80.06M	103M
Imputed Operating Lease Depreciation	272M	126M	182M	122M	272M
Maintenance & Repair Expenses, Total	5.52M	5.27M	11.59M	15.87M	21.76M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14.62B	8B	5.77B	8.93B	8.07B
Short Term Investments	-	-	5B	1.35B	-
Total Cash And Short Term Investments	14.62B	8B	10.77B	10.28B	8.07B
Accounts Receivable, Total	8.08B	13.43B	14.35B	10.02B	9.81B
Other Receivables	6.2B	8.72B	9.68B	5.94B	1.4B
Notes Receivable	102M	57.5M	60.83M	160M	200M
Total Receivables	14.37B	22.2B	24.09B	16.12B	11.41B
Prepaid Expenses	425M	489M	481M	534M	410M
Other Current Assets, Total	501M	290M	705M	727M	2.59B
Total Current Assets	29.92B	30.98B	36.05B	27.66B	22.48B
Gross Property Plant And Equipment	8.29B	9.38B	9.33B	9.79B	9.73B
Accumulated Depreciation	-4.8B	-5.51B	-6.46B	-7.09B	-8B
Net Property Plant And Equipment	3.49B	3.87B	2.87B	2.7B	1.73B
Long-term Investments	2.14B	2.2B	7.28B	6.81B	20.04B
Other Intangibles, Total	529M	570M	466M	373M	254M
Accounts Receivable Long-Term	-	3.91B	2.93B	1.92B	881M
Deferred Tax Assets Long-Term	2.95B	3.36B	3.27B	2.92B	2.99B
Deferred Charges Long-Term	9.88B	4.9B	0	0	0
Other Long-Term Assets, Total	3.97B	5.63B	6.41B	4.42B	355M
Total Assets	52.89B	55.41B	59.26B	46.81B	48.72B
Liabilities
Accounts Payable, Total	1.88B	8.44B	2.84B	1.51B	1.89B
Accrued Expenses, Total	1.18B	2.23B	1.9B	1.74B	1.75B
Short-term Borrowings	4.1B	4.1B	5B	900M	1.96B
Current Portion of Leases	548M	953M	732M	868M	784M
Current Income Taxes Payable	10.96M	1.79M	1.77M	3.63M	34.39M
Other Current Liabilities	4.12B	4.78B	11.42B	4.23B	3.64B
Total Current Liabilities	11.83B	20.51B	21.89B	9.25B	10.07B
Long-Term Leases	1.6B	1.59B	986M	784M	285M
Pension & Other Post Retirement Benefits	5.58B	-	-	-	-
Other Non Current Liabilities	260	1.68B	2.22B	2.01B	1.74B
Total Liabilities	19.01B	23.77B	25.1B	12.05B	12.09B
Common Stock, Total	3.19B	3.19B	3.42B	3.42B	3.42B
Additional Paid In Capital	16.18B	16.18B	26.18B	26.19B	26.19B
Retained Earnings	20.33B	16.6B	7.02B	8.17B	10.47B
Treasury Stock	-1.53B	-1.53B	-1.36B	-1.36B	-1.36B
Comprehensive Income and Other	-4.29B	-2.81B	-1.1B	-1.66B	-2.08B
Total Common Equity	33.88B	31.64B	34.16B	34.76B	36.63B
Minority Interest	-	-	-	-	-
Total Equity	33.88B	31.64B	34.16B	34.76B	36.63B
Total Liabilities And Equity	52.89B	55.41B	59.26B	46.81B	48.72B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	12.51M	12.51M	13.44M	13.44M	13.44M
ECS Total Common Shares Outstanding	12.51M	12.51M	13.44M	13.44M	13.44M
Book Value / Share	2.71K	2.53K	2.54K	2.59K	2.73K
Tangible Book Value	33.35B	31.07B	33.7B	34.39B	36.38B
Tangible Book Value Per Share	2.67K	2.48K	2.51K	2.56K	2.71K
Total Debt	6.24B	6.64B	6.72B	2.55B	3.03B
Net Debt	-8.38B	-1.36B	-4.05B	-7.73B	-5.04B
Debt Equivalent Oper. Leases	2.83B	1.35B	2.38B	1.61B	3.01B
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Machinery, Total	4.15B	4.27B	4.43B	4.64B	4.73B
Accumulated Allowance for Doubtful Accounts (Supple)	89.24M	1.87B	2.4B	572M	474M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-7.92B	-3.19B	-9.59B	1.21B	2.29B
Depreciation & Amortization - CF	1B	1.26B	1.21B	1.32B	1.29B
Amortization of Goodwill and Intangible Assets - (CF)	1.74B	1.21B	730M	117M	122M
Depreciation & Amortization, Total	2.74B	2.47B	1.94B	1.44B	1.42B
(Gain) Loss From Sale Of Asset	-33.75M	-965K	-460K	-1.25M	26.48M
(Gain) Loss on Sale of Investments - (CF)	-1.45B	-57.08M	-80.62M	-78M	-268M
Asset Writedown & Restructuring Costs	4.96B	3.88B	4.29B	-	199M
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-87.89M	1.8B	2.19B	-1.26B	-152M
Other Operating Activities, Total	2.9B	3.97B	58.78M	2.25B	2.49B
Change In Accounts Receivable	6.43B	-14.49B	1.13B	11.28B	8.56B
Change In Accounts Payable	-4.35B	6.65B	-5.55B	-1.23B	-1.8B
Change in Other Net Operating Assets	79.94M	-5.59B	3.96B	-9B	-1.89B
Cash from Operations	3.26B	-4.57B	-1.65B	4.6B	10.87B
Capital Expenditure	-452M	-487M	-338M	-382M	-250M
Sale of Property, Plant, and Equipment	-	-	-	1.25M	5M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-354M	-150M	-12M	-25.04M	-11.6M
Investment in Marketable and Equity Securities, Total	1.68B	-	-10B	4.14B	-11.6B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-2.5M	45M	-3.33M	-99.17M	-40.42M
Other Investing Activities, Total	66.07M	101M	-210M	-4.26M	-234M
Cash from Investing	937M	-491M	-10.56B	3.63B	-12.13B
Short Term Debt Issued, Total	4.1B	-	-	-	-
Long-Term Debt Issued, Total	-	-	3.9B	-	1.83B
Total Debt Issued	4.1B	-	3.9B	-	1.83B
Long-Term Debt Repaid, Total	-594M	-845M	-3.78B	-5B	-1.82B
Total Debt Repaid	-594M	-845M	-3.78B	-5B	-1.82B
Issuance of Common Stock	-	-	9.9B	-	-
Repurchase of Common Stock	-48.67M	-	-	-	-
Common & Preferred Stock Dividends Paid	-537M	-538M	-	-	-
Common & Preferred Stock Dividends Paid	-537M	-538M	-	-	-
Other Financing Activities, Total	-	-835K	-4M	-	-
Cash from Financing	2.92B	-1.38B	10.02B	-5B	10.87M
Foreign Exchange Rate Adjustments	-395M	-185M	-31.3M	-82.87M	387M
Net Change in Cash	6.72B	-6.63B	-2.22B	3.16B	-862M
Supplemental Items
Cash Interest Paid	68.46M	117M	241M	158M	36.66M
Cash Income Tax Paid (Refund)	625M	1.58B	965M	224M	439M
Levered Free Cash Flow	6.16B	2.67B	-2.78B	257M	5.29B
Unlevered Free Cash Flow	6.23B	2.8B	-2.58B	401M	5.35B
Change In Net Working Capital	-6.77B	-593M	1.59B	777M	-2.81B
Net Debt Issued / Repaid	3.51B	-845M	124M	-5B	10.87M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-4.45	0.68	-4.49	0.28	2.89
Return on Total Capital	-5.97	0.94	-6.51	0.38	3.59
Return On Equity %	-21.01	-9.74	-29.14	3.5	6.42
Return on Common Equity	-21.01	-9.74	-29.14	3.5	6.42
Margin Analysis
Gross Profit Margin %	13.33	18.66	14.03	17.57	21.75
SG&A Margin	13.74	12.45	12.24	14.93	14.71
EBITDA Margin %	-1.6	3.32	-2.98	2.46	4.99
EBITA Margin %	-2.9	1.95	-4.63	0.52	3.21
EBIT Margin %	-5.16	0.64	-5.63	0.35	3.04
Income From Continuing Operations Margin %	-10.3	-3.47	-13.1	1.78	3.16
Net Income Margin %	-10.3	-3.47	-13.1	1.78	3.16
Net Avail. For Common Margin %	-10.3	-3.47	-13.1	1.78	3.16
Normalized Net Income Margin	-3.49	0.96	-4.15	1.67	2.46
Levered Free Cash Flow Margin	8.01	2.9	-3.79	0.38	7.28
Unlevered Free Cash Flow Margin	8.1	3.04	-3.52	0.59	7.36
Asset Turnover
Asset Turnover	1.38	1.7	1.28	1.28	1.52
Fixed Assets Turnover	24.9	25.03	21.73	24.39	32.79
Receivables Turnover (Average Receivables)	6.43	8.56	5.27	5.58	7.33
Short Term Liquidity
Current Ratio	2.53	1.51	1.65	2.99	2.23
Quick Ratio	2.44	1.47	1.59	2.84	1.92
Operating Cash Flow to Current Liabilities	0.28	-0.22	-0.08	0.5	1.08
Days Sales Outstanding (Average Receivables)	56.75	42.62	69.27	65.63	49.81
Average Days Payable Outstanding	22.2	25.13	32.7	14.2	10.92
Long Term Solvency
Total Debt/Equity	18.43	20.99	19.67	7.34	8.28
Total Debt / Total Capital	15.56	17.35	16.43	6.84	7.64
LT Debt/Equity	4.71	5.02	2.89	2.25	0.78
Long-Term Debt / Total Capital	3.98	4.15	2.41	2.1	0.72
Total Liabilities / Total Assets	35.94	42.9	42.36	25.74	24.82
EBIT / Interest Expense	-35.64	2.9	-12.74	1.03	23.05
EBITDA / Interest Expense	-11.03	15.03	-6.74	7.27	37.81
(EBITDA - Capex) / Interest Expense	-15.1	12.64	-7.78	5.61	35.21
Total Debt / EBITDA	-5.08	2.17	-3.08	1.52	0.84
Net Debt / EBITDA	6.83	-0.44	1.86	-4.62	-1.39
Total Debt / (EBITDA - Capex)	-3.72	2.58	-2.67	1.98	0.9
Net Debt / (EBITDA - Capex)	4.99	-0.53	1.61	-5.99	-1.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.91	19.72	-20.51	-7.17	6.92
Gross Profit, 1 Yr. Growth %	6.01	67.67	-40.25	16.23	32.39
EBITDA, 1 Yr. Growth %	-9.49	-349.28	-171.17	-176.86	116.62
EBITA, 1 Yr. Growth %	9.35	-180.62	-288.62	-110.43	560.18
EBIT, 1 Yr. Growth %	86.27	-114.91	-796.95	-105.73	836.51
Earnings From Cont. Operations, 1 Yr. Growth %	444.57	-59.71	200.47	-112.6	89.86
Net Income, 1 Yr. Growth %	699.18	-59.71	200.47	-112.6	89.86
Normalized Net Income, 1 Yr. Growth %	181.62	-132.73	-445.74	-137.22	57.98
Diluted EPS Before Extra, 1 Yr. Growth %	456.21	-59.78	197.65	-111.84	89.78
Accounts Receivable, 1 Yr. Growth %	-49.01	66.25	6.87	-30.2	-2.07
Net Property, Plant and Equip., 1 Yr. Growth %	29.8	10.83	-25.83	-5.73	-36.16
Total Assets, 1 Yr. Growth %	-9.46	4.78	6.95	-21.02	4.1
Tangible Book Value, 1 Yr. Growth %	-19.19	-6.85	8.46	2.05	5.79
Common Equity, 1 Yr. Growth %	-18.38	-6.62	7.97	1.75	5.38
Cash From Operations, 1 Yr. Growth %	-142.25	-240.06	-63.92	-379.27	136.11
Capital Expenditures, 1 Yr. Growth %	-40.42	7.65	-30.61	13.22	-34.64
Levered Free Cash Flow, 1 Yr. Growth %	-147.93	-56.67	-204.1	-109.27	1.95K
Unlevered Free Cash Flow, 1 Yr. Growth %	-148.55	-55.11	-192.13	-115.58	1.23K
Dividend Per Share, 1 Yr. Growth %	0	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	18.48	19.32	-2.45	-14.1	-0.37
Gross Profit, 2 Yr. CAGR %	-0.51	33.32	0.09	-16.66	24.05
EBITDA, 2 Yr. CAGR %	-44.59	50.21	33.2	-26.04	29.03
EBITA, 2 Yr. CAGR %	-22.65	-6.11	23.31	-55.66	-17.04
EBIT, 2 Yr. CAGR %	4.08	-47.3	1.93	-36.81	-26.75
Earnings From Cont. Operations, 2 Yr. CAGR %	40.87	48.12	10.03	-38.48	-51.1
Net Income, 2 Yr. CAGR %	42.48	79.44	10.03	-38.48	-51.1
Normalized Net Income, 2 Yr. CAGR %	-3.35	-3.99	6.38	13.44	-23.32
Diluted EPS Before Extra, 2 Yr. CAGR %	25.5	49.56	9.41	-40.64	-52.6
Accounts Receivable, 2 Yr. CAGR %	13.65	-7.92	33.3	-13.63	-17.32
Net Property, Plant and Equip., 2 Yr. CAGR %	116.03	19.94	-9.33	-16.38	-22.42
Total Assets, 2 Yr. CAGR %	-4.37	-2.6	5.86	-8.09	-9.33
Tangible Book Value, 2 Yr. CAGR %	-14.66	-13.24	0.51	5.2	3.9
Common Equity, 2 Yr. CAGR %	-14.27	-12.69	0.41	4.82	3.55
Cash From Operations, 2 Yr. CAGR %	21.09	-23.07	-28.91	0.38	156.78
Capital Expenditures, 2 Yr. CAGR %	11.78	-19.92	-13.57	-11.37	-13.98
Levered Free Cash Flow, 2 Yr. CAGR %	57.12	-54.43	-32.84	-68.94	37.95
Unlevered Free Cash Flow, 2 Yr. CAGR %	58.01	-53.32	-35.69	-62.12	44.07
Dividend Per Share, 2 Yr. CAGR %	0	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.57	18.89	4.21	-4.05	-7.6
Gross Profit, 3 Yr. CAGR %	-2.78	18.4	2.03	5.21	-2.76
EBITDA, 3 Yr. CAGR %	-36.54	-8.53	17.1	10.89	5.82
EBITA, 3 Yr. CAGR %	-21.2	-21.57	18.47	-45.88	9.09
EBIT, 3 Yr. CAGR %	-4.07	-45.54	24.62	-60.95	55.22
Earnings From Cont. Operations, 3 Yr. CAGR %	29.99	-7.18	87.51	-46.57	-10.43
Net Income, 3 Yr. CAGR %	30.78	-6.48	113.08	-46.57	-10.43
Normalized Net Income, 3 Yr. CAGR %	0.29	-32.63	47.16	-25.04	26.68
Diluted EPS Before Extra, 3 Yr. CAGR %	20.99	-14.12	88.12	-47.87	-12.56
Accounts Receivable, 3 Yr. CAGR %	-12.14	29.01	-3.23	7.44	-9.94
Net Property, Plant and Equip., 3 Yr. CAGR %	74.31	72.94	2.19	-8.15	-23.58
Total Assets, 3 Yr. CAGR %	10.48	-1.41	0.48	-3.99	-4.2
Tangible Book Value, 3 Yr. CAGR %	5.87	-12.13	-6.54	1.02	5.4
Common Equity, 3 Yr. CAGR %	5.71	-11.79	-6.29	0.86	5
Cash From Operations, 3 Yr. CAGR %	-2.12	27.11	-40.23	12.17	33.5
Capital Expenditures, 3 Yr. CAGR %	21.47	10.39	-23.65	-5.43	-19.92
Levered Free Cash Flow, 3 Yr. CAGR %	23.31	2.27	-39.98	-65.3	25.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.77	3.87	-41.44	-59.91	24.12
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	11.71	5.74	4.4	2.35
Gross Profit, 5 Yr. CAGR %	-	12.68	-1.64	2.88	10.32
EBITDA, 5 Yr. CAGR %	-	-7.1	-14.63	-15.98	21.74
EBITA, 5 Yr. CAGR %	-	-15.47	-5.74	-37.57	2.74
EBIT, 5 Yr. CAGR %	-	-32.12	-1.71	-42.2	0.76
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-2.81	21.6	-21.26	9.53
Net Income, 5 Yr. CAGR %	-	-2.81	22.05	-20.9	18.27
Normalized Net Income, 5 Yr. CAGR %	-	-21.2	2.68	-17.02	13.38
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-7.27	16.22	-25.92	8.38
Accounts Receivable, 5 Yr. CAGR %	-	3.52	3.8	9.88	-9.14
Net Property, Plant and Equip., 5 Yr. CAGR %	-	42.67	34.21	29.32	-8.48
Total Assets, 5 Yr. CAGR %	-	10.55	8.61	-4.14	-3.56
Tangible Book Value, 5 Yr. CAGR %	-	4.68	3.7	-5.57	-2.49
Common Equity, 5 Yr. CAGR %	-	4.54	3.56	-5.49	-2.47
Cash From Operations, 5 Yr. CAGR %	-	-1.35	-13.88	15.66	7.08
Capital Expenditures, 5 Yr. CAGR %	-	15.78	6.01	1.11	-19.92
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-3.3	-36.51	-16.28
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-4.75	-30.61	-16.06